Patents Represented by Attorney Mark T. Flehr Hohbach Test Albritton and Herbert Kresnak
  • Patent number: 5830713
    Abstract: Methods are provided for the production of large polypeptides containing repeating sequences of amino acids utilizing biochemical techniques, specifically DNA sequences coding for the expression of the large polypeptides. Systems utilizing exogenous transcriptional and translational regions to control the production of the large polypeptides are also provided.
    Type: Grant
    Filed: September 3, 1996
    Date of Patent: November 3, 1998
    Assignee: Protein Polymer Technologies, Inc.
    Inventors: Franco A. Ferrari, Joseph Cappello, John W. Crissman, Mary A. Dorman
  • Patent number: 5827822
    Abstract: Cyclosporin A formulations are provided as amorphous nanoparticle dispersions for physiologic absorption. The compositions have high bioavailability and patient acceptability. By providing for concentrates comprising lower alkanols and a polyoxyalkylene surfactant as a stable dispersion of cyclosporin A, upon introducing the stable dispersion into an aqueous medium, the subject formulation is produced comprising amorphous bioavailable cyclosporin nanoparticles.
    Type: Grant
    Filed: March 25, 1996
    Date of Patent: October 27, 1998
    Assignee: Sangstat Medical Corporation
    Inventors: Robert Floc'h, Christian Merle
  • Patent number: 5817303
    Abstract: Proteinaceous polymers having repetitive units from naturally occurring structural proteins are employed as backbones for functionalities for crosslinking to provide strongly adherent tissue adhesives and sealants. Particularly, block copolymers having repeating units of elastin and fibroin are employed having lysine substitutions in spaced apart units, where the amino group can be crosslinked using difunctional crosslinking agents. The protein polymer contains at least 40 weight percent of repetitive units of 3 to 15 amino acids of at least one naturally occurring protein and in at least two units an amino acid is substituted by an amino acid containing a functional group capable of reacting with a crosslinking agent to form a strongly adherent adhesive composition for bonding together separated tissue or for sealing tissue defects.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: October 6, 1998
    Assignee: Protein Polymer Technologies, Inc.
    Inventors: Erwin R. Stedronsky, Joseph Cappello
  • Patent number: 5808012
    Abstract: Thermoplastics interdispersed with a variety of functional thermostable proteins and methods for their production are provided. To prepare the subject thermoplastics, a plastic material is contacted with a thermostable polypeptide and then subjected to the heating and molding/extrusion/casting process. The resultant thermoplastics comprise the thermostable polypeptide on the formed plastic surface and at a depth below the plastic surface. The thermostable polypeptides contained in the disclosed compositions retain functional properties or binding specificities through the heating and molding/extrusion/casting processes. Preferred thermostable polypeptides used in the disclosed compositions include silk-like protein polymers, particularly ProNectin.RTM.F. The disclosed methods and compositions find use in many applications where plastics containing finctional thermostable proteins are desired, in particular, cell cultureware.
    Type: Grant
    Filed: January 16, 1996
    Date of Patent: September 15, 1998
    Assignee: Protein Polymer Technologies, Inc.
    Inventors: David M. Donofrio, Erwin R. Stedronsky